换一批
换一批Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
作者：
Hiroki,Maruyama [1]
;
Kaori,Miyata [2]
;
Mariko,Mikame [3]
;
Atsumi,Taguchi [3]
;
Chu,Guili [3]
;
Masaru,Shimura [4]
;
Kei,Murayama [4]
;
Takeshi,Inoue [5]
;
Saori,Yamamoto [6]
;
Koichiro,Sugimura [6]
;
Koichi,Tamita [7]
;
Toshihiro,Kawasaki [7]
;
Jun,Kajihara [8]
;
Akifumi,Onishi [9]
;
Hitoshi,Sugiyama [9]
;
Teiko,Sakai [10]
;
Ichijiro,Murata [11]
;
Takamasa,Oda [12]
;
Shigeru,Toyoda [13]
;
Kenichiro,Hanawa [14]
;
Takeo,Fujimura [15]
;
Shigehisa,Ura [16]
;
Mimiko,Matsumura [17]
;
Hideki,Takano [17]
;
Satoshi,Yamashita [18]
;
Gaku,Matsukura [18]
;
Ryushi,Tazawa [19]
;
Tsuyoshi,Shiga [20]
;
Mio,Ebato [21]
;
Hiroshi,Satoh [22]
;
Satoshi,Ishii [23]
作者单位：
Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. hirokim@med.niigata-u.ac.jp.
[1]
Sanofi K.K., Sanofi Genzyme Medical Operations, Rare Disease Medical, Medical Science Liaison, Tokyo, Japan.
[2]
Department of Clinical Nephroscience, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
[3]
Department of Metabolism, Chiba Children's Hospital, Chiba, Japan.
[4]
Department of Pediatrics, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Japan.
[5]
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
[6]
Nishinomiya Watanabe Cardiovascular Center, Nishinomiya, Japan.
[7]
Department of Cardiology, Fujinomiya City General Hospital, Fujinomiya, Japan.
[8]
Department of Human Resource Development of Dialysis Therapy for Kidney Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama, Japan.
[9]
Sukoyaka Clinic, Gifu, Japan.
[10]
Department of Chronic Kidney Disease, Gifu University Graduate School of Medicine, Gifu, Japan.
[11]
Yamaguchi Prefectural Grand Medical Center, Hofu, Japan.
[12]
Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Japan.
[13]
Department of Cardiology, Internal Medicine, Iwaki Kyoritsu General Hospital, Iwaki, Japan.
[14]
Department of Nephrology, Kashiwazaki General Hospital and Medical Center, Kashiwazaki, Japan.
[15]
Division of Neurology, Japanese Red Cross Asahikawa Hospital, Asahikawa, Japan.
[16]
Department of Nephrology, Tokyo Teishin Hospital, Tokyo, Japan.
[17]
Department of Cardiology, Japanese Red Cross Hamamatsu Hospital, Hamamatsu, Japan.
[18]
Division of Medical Genetics, Bioscience Medical Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.
[19]
Department of Cardiology, Tokyo Women's Medical University, Tokyo, Japan.
[20]
Division of Cardiology, Showa University Fujigaoka Hospital, Yokohama, Japan.
[21]
Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Hamamatsu, Japan.
[22]
Glyco Pharma Corporation, Oita, Japan.
[23]
DOI
10.1038/s41436-019-0447-8
PMID
30728527
发布时间
2022-02-11
- 浏览12
Genetics in medicine
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
